Cisplatin for neoplasm metastasis

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 20 Jan 2025: Trial registered, NCT06783140
  2. 10 Jun 2025: Trial started, NCT06783140

The trials

NCT06783140: Study of NABPLAGEM vs. Nab-Paclitaxel/Gemcitabine in BRCA1/2 or PALB2 Pancreatic Cancer

State
Under way
Phase
Phase 2 and Phase 3
People
10 planned
Started
10 Jun 2025
Primary completion
2 Jun 2031
Arms
Arm 1- NABPLAGEM (Nab-paclitaxel+Cisplatin+Gemcitabine)
Results
None posted
  1. 20 Jan 2025: Trial registered
  2. 10 Jun 2025: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Kind of treatment: Drug.

Also known as Cisplatin for injection, Liplacis, Platinol.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.